Publication:
Understanding heterogeneity in biologic phenotypes of acute respiratory distress syndrome by leukocyte expression profiles

dc.contributor.authorLieuwe D.J. Bosen_US
dc.contributor.authorBrendon P. Sciclunaen_US
dc.contributor.authorDavid S.Y. Ongen_US
dc.contributor.authorOlaf Cremeren_US
dc.contributor.authorTom Van Der Pollen_US
dc.contributor.authorMarcus J. Schultzen_US
dc.contributor.otherUniversity Medical Center Utrechten_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherAmsterdam UMC - University of Amsterdamen_US
dc.date.accessioned2020-01-27T10:30:46Z
dc.date.available2020-01-27T10:30:46Z
dc.date.issued2019-01-01en_US
dc.description.abstract© 2019 by the American Thoracic Society. Rationale: Two biologic phenotypes of acute respiratory distress syndrome (ARDS) have been identified based on plasma protein markers in four previous studies. Objectives: To determine if blood leukocyte gene expression is different between the "reactive" and "uninflamed" phenotype. Methods: This is a new study adding blood leukocyte transcriptomics and bioinformatics analysis to an existing patient cohort of ARDS in patients with sepsis admitted to two ICUs during a 1.5-year period. Canonical pathway analysis was performed. Measurements and Main Results: A total of 210 patients with sepsis and ARDS were included, of whom 128 had a reactive and 82 an uninflamed phenotype. A total of 3,332/11,443 (29%) transcripts were significantly different between the phenotypes. Canonical pathway analysis showed upregulation of oxidative phosphorylation genes indicative of mitochondrial dysfunction (52% of genes in pathway). The uninflamed phenotype was characterized by upregulation of mitogen-activated protein kinase pathways. Conclusions: A third of genes are differentially expressed between biologic phenotypes of ARDS supporting the observation that the subgroups of ARDS are incomparable in terms of pathophysiology. These data provide additional support for biologic heterogeneity in patients with ARDS and suggests that a personalized approach to intervention focusing on oxidative phosphorylation is pivotal in this condition.en_US
dc.identifier.citationAmerican Journal of Respiratory and Critical Care Medicine. Vol.200, No.1 (2019), 42-50en_US
dc.identifier.doi10.1164/rccm.201809-1808OCen_US
dc.identifier.issn15354970en_US
dc.identifier.issn1073449Xen_US
dc.identifier.other2-s2.0-85065716353en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/52263
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065716353&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleUnderstanding heterogeneity in biologic phenotypes of acute respiratory distress syndrome by leukocyte expression profilesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065716353&origin=inwarden_US

Files

Collections